Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity

• Main Authors: Huaqing Jing (Author), Yingzi Ren (Author), Yue Zhou (Author), Min Xu (Author), Sona Krizkova (Author), Zbynek Heger (Author), Qiang Lu (Author), Siyu Wang (Author), Xiaoyang Liang (Author), Vojtech Adam (Author), Nan Li (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Liver fibrosis is a reversible pathological process caused by chronic liver damage and a major risk factor for hepatocellular carcinoma (HCC). Hepatic stellate cell (HSC) activation is considered the main target for liver fibrosis therapy. However, the efficiency of this strategy is limited due to t...